A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds ...

A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

Others generate consistent and reliable dividends over the long run. Chevron (NYSE: CVX) has increased its dividend for 37 ...

A study found that some long COVID patients who took Paxlovid saw improvement. But experts said the research isn't enough to ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

In the winter, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds. But there are things you ...

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...

By Pam Belluck Pam Belluck has covered long Covid since the condition first emerged. Can Paxlovid treat long Covid? A new report suggests it might help some patients, but which patients might ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.